Found: 8
Select item for more details and to access through your institution.
Anti-cancer drug combinations approved by US FDA from 2011 to 2021: main design features of clinical trials and role of pharmacokinetics.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Population pharmacokinetics of cisplatin in small cell lung cancer patients guided with informative priors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Physiologically based pharmacokinetic modeling of ponatinib to describe drug-drug interactions in patients with cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effect of fluconazole on the pharmacokinetics of a single dose of fedratinib in healthy adults.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Potentiation of temozolomide activity against glioblastoma cells by aromatase inhibitor letrozole.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Absorption, metabolism and excretion of [<sup>14</sup>C]-sotorasib in healthy male subjects: characterization of metabolites and a minor albumin-sotorasib conjugate.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Model-informed approach for risk management of bleeding toxicities for bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1.
- Published in:
- 2022
- By:
- Publication type:
- journal article